Evidence map›Paper›PMID 41994299›Full record

ArticleInternational journal of women's health2026

Global, Regional, and National Impact of Pelvic Inflammatory Disease: Changing Landscape from 1990 to 2021.

Pei-Yu Chen, Jian-Bo Wei, Shuang-Shuang Guo, Yu-Hao Jiang, Xiao-Fei Li, Luo-Jiao Liang, Yun-Qiu Zhang, Fan-Ke Zeng, Ding-Feng Wu, Wei Wang and 1 more

Abstract read
In one paragraph

Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pei-Yu Chen *Department of Obstetrics and Gynecology, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510120, People's Republic of China.
Jian-Bo Wei *Department of Obstetrics and Gynecology, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510120, People's Republic of China.
Shuang-Shuang GuoDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510120, People's Republic of China.
Yu-Hao JiangDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510120, People's Republic of China.
Xiao-Fei LiDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510120, People's Republic of China.
Luo-Jiao LiangDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510120, People's Republic of China.
Yun-Qiu ZhangDepartment of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, People's Republic of China.
Fan-Ke ZengDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510120, People's Republic of China.
Ding-Feng WuDepartment of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, People's Republic of China.ORCID 0000-0002-9287-122X
Wei WangDepartment of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, People's Republic of China.ORCID 0009-0004-4049-5279
Liang-Sheng FanDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510120, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pelvic inflammatory disease (PID) is a polymicrobial infection of the upper female genital tract affecting women globally. The study aimed to assess the global prevalence and years lived with disability (YLDs) of PID from 1990 to 2021 and analyze influencing factors. Methods: The 2021 Global Burden of Disease (GBD) dataset provided data on the PID statistics of women of childbearing age (15-49 years), including case counts and age-standardized rates (ASRs). Trends were assessed using estimated annual percentage changes (EAPCs), while the relation of regions, nations and Socio-demographic Index (SDI) was examined using local weighted regression (Lowess). To predict the burden, the Bayesian age-period-cohort (BAPC) model was devised. Results: The GBD data show PID burden negatively correlated with SDI: the age-standardized prevalence rate (ASPR) and the age-standardized years lived with disability rate (ASYR) were higher in low-SDI regions (eg, sub-Saharan Africa) and lower in high-SDI regions (eg, Western Europe). In 2021, rates were 27.02 and 3.68 per 100,000, respectively. Country disparities are marked (Guinea-Bissau highest). Burden peaks at ages 30-39. Projections show persistent increases in both rates across childbearing ages through 2050. Conclusion: Through severity-stratified estimations, detailed cause-specific burden analysis, and BAPC projection modeling, this study provides a comprehensive and detailed description of the global burden and epidemiological trends of PID. Despite overall progress, persistent disparities remain notably the disproportionately high burden in low-SDI regions such as sub-Saharan Africa and Eastern Europe. These projections underscore an urgent need for context-specific prevention strategies, including strengthened STI screening and treatment, improved antibiotic access, and community-based sexual health education tailored to local health system capacity.

Indexed as

age-standardized prevalence rateage-standardized YLDs rateglobal burden of diseasepelvic inflammatory diseasesocio-demographic index

Identifiers

PMID41994299
PMCPMC13080721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.